Monoclonal antibody P1H12 recognizes circulating endothelial cells and endo
thelia of all sizes of blood vessels. To identify the protein recognized by
P1H12, we expressed a cDNA library in CHO cells and sequenced the cDNA fro
m positive cells. The P1H12 sequence was identical, except at several bases
, to that reported for melanoma cell surface antigen MUC18/CD146. Aggregati
on assays demonstrated that CD146 mediates Ca++-independent homotypic endot
helial cell adhesion. P1H12 mAb abrogated interactions between human microv
ascular endothelial cells (HMVECs) but not between human umbilical vein end
othelial cells (HUVECs). P1H12 mAb abrogated P1H12-positive (CHOP1H12)-asso
ciation with HMVECs or HUVECs. CD146 distribution is sparser on HUVECs than
on HMVECs. These data imply that HMVECs and HUVECs express the CD146 bindi
ng partner but that CD146 is functional (or at sufficient density) only on
HMVECs. HMVEC monolayers treated with soluble P1H12 mAb showed increased pe
rmeability to albumin, with accompanying changes in actin, paxillin, FAK, a
nd caveolin distribution and changes in tyrosine phosphorylation of FAK. St
imulation with P1H12 mAb led to redistribution of NF-kappaB to the nucleus.
P1H12 mAb bound to beads inhibited closure of wounded endothelial monolaye
rs. CD146 thus joins VE-cadherin and PECAM-1 as a molecule that mediates ho
motypic endothelial cell adhesion. CD146 has both structural functions and
signaling functions important for endothelial monolayer integrity.